201 related articles for article (PubMed ID: 34002001)
1. Serum iron and risk of nonalcoholic fatty liver disease and advanced hepatic fibrosis in US adults.
Yang HH; Chen GC; Li DM; Lan L; Chen LH; Xu JY; Qin LQ
Sci Rep; 2021 May; 11(1):10387. PubMed ID: 34002001
[TBL] [Abstract][Full Text] [Related]
2. Increased serum selenium levels are associated with reduced risk of advanced liver fibrosis and all-cause mortality in NAFLD patients: National Health and Nutrition Examination Survey (NHANES) III.
Reja M; Makar M; Visaria A; Marino D; Rustgi V
Ann Hepatol; 2020; 19(6):635-640. PubMed ID: 32745632
[TBL] [Abstract][Full Text] [Related]
3. Association between handgrip strength, nonalcoholic fatty liver disease, advanced hepatic fibrosis and its modifiers: Evidence from the NHANES database of the USA.
Zhao X; Shi X; Gu H; Zhou W; Zhang Q
J Gastroenterol Hepatol; 2023 Oct; 38(10):1734-1742. PubMed ID: 36805682
[TBL] [Abstract][Full Text] [Related]
4. Association of iron status with non-alcoholic fatty liver disease and liver fibrosis in US adults: a cross-sectional study from NHANES 2017-2018.
Tan L; Zhou Q; Liu J; Liu Z; Shi R
Food Funct; 2023 Jun; 14(12):5653-5662. PubMed ID: 37249386
[No Abstract] [Full Text] [Related]
5. Visceral-to-Subcutaneous Abdominal Fat Ratio Is Associated with Nonalcoholic Fatty Liver Disease and Liver Fibrosis.
Jung CH; Rhee EJ; Kwon H; Chang Y; Ryu S; Lee WY
Endocrinol Metab (Seoul); 2020 Mar; 35(1):165-176. PubMed ID: 32207277
[TBL] [Abstract][Full Text] [Related]
6. Significant burden of nonalcoholic fatty liver disease with advanced fibrosis in the US: a cross-sectional analysis of 2011-2014 National Health and Nutrition Examination Survey.
Wong RJ; Liu B; Bhuket T
Aliment Pharmacol Ther; 2017 Nov; 46(10):974-980. PubMed ID: 28914448
[TBL] [Abstract][Full Text] [Related]
7. Serum zinc level and hepatic fibrosis in patients with nonalcoholic fatty liver disease.
Kim MC; Lee JI; Kim JH; Kim HJ; Cho YK; Jeon WK; Kim BI; Sohn W
PLoS One; 2020; 15(10):e0240195. PubMed ID: 33095789
[TBL] [Abstract][Full Text] [Related]
8. Serum folate associated with nonalcoholic fatty liver disease and advanced hepatic fibrosis.
Chen HK; Luo J; Li XJ; Liao WZ; Hu YQ; Guo XG
Sci Rep; 2023 Aug; 13(1):12933. PubMed ID: 37558738
[TBL] [Abstract][Full Text] [Related]
9. Associations of different serum folate forms with indices of nonalcoholic fatty liver disease and advanced fibrosis.
Yang S; Ye Z; Liu M; Zhang Y; Wu Q; Zhou C; Zhang Z; He P; Zhang Y; Li H; Liu C; Qin X
Obes Res Clin Pract; 2023; 17(1):58-65. PubMed ID: 36746711
[TBL] [Abstract][Full Text] [Related]
10. Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease.
Kowdley KV; Belt P; Wilson LA; Yeh MM; Neuschwander-Tetri BA; Chalasani N; Sanyal AJ; Nelson JE;
Hepatology; 2012 Jan; 55(1):77-85. PubMed ID: 21953442
[TBL] [Abstract][Full Text] [Related]
11. Association between Liver Fibrosis and Serum PSA among U.S. Men: National Health and Nutrition Examination Survey (NHANES), 2001-2010.
Wang A; Lazo M; Carter HB; Groopman JD; Nelson WG; Platz EA
Cancer Epidemiol Biomarkers Prev; 2019 Aug; 28(8):1331-1338. PubMed ID: 31160348
[TBL] [Abstract][Full Text] [Related]
12. The association between non-alcoholic fatty liver disease and serum ferritin levels in American adults.
Yang N; Lu Y; Cao L; Lu M
J Clin Lab Anal; 2022 Feb; 36(2):e24225. PubMed ID: 34997649
[TBL] [Abstract][Full Text] [Related]
13. Daily Aspirin Use Associated With Reduced Risk For Fibrosis Progression In Patients With Nonalcoholic Fatty Liver Disease.
Simon TG; Henson J; Osganian S; Masia R; Chan AT; Chung RT; Corey KE
Clin Gastroenterol Hepatol; 2019 Dec; 17(13):2776-2784.e4. PubMed ID: 31077838
[TBL] [Abstract][Full Text] [Related]
14. Shiftwork Is Not Associated with Increased Risk of NAFLD: Findings from the National Health and Nutrition Examination Survey.
Balakrishnan M; El-Serag HB; Kanwal F; Thrift AP
Dig Dis Sci; 2017 Feb; 62(2):526-533. PubMed ID: 27995401
[TBL] [Abstract][Full Text] [Related]
15. Association between Serum Ferritin Levels and Metabolic-associated Fatty Liver Disease in Adults: a Cross-sectional Study Based on the NHANES.
Li JH; Ma XY; Yi Y; Li LR; Xu ZY; Chang Y
Curr Med Sci; 2024 Jun; 44(3):494-502. PubMed ID: 38748368
[TBL] [Abstract][Full Text] [Related]
16. Predictors of advanced fibrosis in elderly patients with biopsy-confirmed nonalcoholic fatty liver disease: the GOASIA study.
Pitisuttithum P; Chan WK; Piyachaturawat P; Imajo K; Nakajima A; Seki Y; Kasama K; Kakizaki S; Fan JG; Song MJ; Yoon SK; Dan YY; Lesmana L; Ho KY; Goh KL; Wong VWS; Treeprasertsuk S
BMC Gastroenterol; 2020 Apr; 20(1):88. PubMed ID: 32252638
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of Nonalcoholic Steatohepatitis-Associated Cirrhosis in the United States: An Analysis of National Health and Nutrition Examination Survey Data.
Kabbany MN; Conjeevaram Selvakumar PK; Watt K; Lopez R; Akras Z; Zein N; Carey W; Alkhouri N
Am J Gastroenterol; 2017 Apr; 112(4):581-587. PubMed ID: 28195177
[TBL] [Abstract][Full Text] [Related]
18. Associations of acrylamide with non-alcoholic fatty liver disease in American adults: a nationwide cross-sectional study.
Liu Z; Wang J; Chen S; Xu C; Zhang Y
Environ Health; 2021 Aug; 20(1):98. PubMed ID: 34461916
[TBL] [Abstract][Full Text] [Related]
19. Blood lead level is associated with advanced liver fibrosis in patients with non-alcoholic fatty liver disease: A nationwide survey (NHANES 2011-2016).
Reja D; Makar M; Visaria A; Karanfilian B; Rustgi V
Ann Hepatol; 2020; 19(4):404-410. PubMed ID: 32376236
[TBL] [Abstract][Full Text] [Related]
20. Noninvasive fibrosis markers and chronic kidney disease among adults with nonalcoholic fatty liver in USA.
Wijarnpreecha K; Thongprayoon C; Scribani M; Ungprasert P; Cheungpasitporn W
Eur J Gastroenterol Hepatol; 2018 Apr; 30(4):404-410. PubMed ID: 29215435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
